BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 20482674)

  • 1. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT; van Belle P; Elenitsas R; Elder DE
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bcl-2 protein expression in melanocytic neoplasms of the skin.
    Ramsay JA; From L; Kahn HJ
    Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the ets-1 proto-oncogene in melanocytic lesions.
    Keehn CA; Smoller BR; Morgan MB
    Mod Pathol; 2003 Aug; 16(8):772-7. PubMed ID: 12920221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
    Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
    Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
    Giehl KA; Nägele U; Volkenandt M; Berking C
    J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
    Zhang H
    Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis.
    Garrido-Ruiz MC; Rodriguez-Pinilla SM; Pérez-Gómez B; Rodriguez-Peralto JL
    J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
    Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
    Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 expression in human melanocytes and melanocytic tumors.
    van den Oord JJ; Vandeghinste N; De Ley M; De Wolf-Peeters C
    Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
    King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
    Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.